Reviewed,
UniProtKB/Swiss-Prot Q8TEW0 (PARD3_HUMAN)
Last modified
February 9, 2010.
Version 86.
History...
Clusters with 100%,
90%,
50% identity |
Documents (6) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Partitioning defective 3 homolog Short name=PARD-3 Short name=PAR-3 Alternative name(s): Atypical PKC isotype-specific-interacting protein Short name=ASIP CTCL tumor antigen se2-5 PAR3-alpha | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Complete proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 1356 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | Adapter protein involved in asymmetrical cell division and cell polarization processes. Seems to play a central role in the formation of epithelial tight junctions. Association with PARD6B may prevent the interaction of PARD3 with F11R/JAM1, thereby preventing tight junction assembly. The PARD6-PARD3 complex links GTP-bound Rho small GTPases to atypical protein kinase C proteins. |
| Subunit structure | Interacts with PARD6A and PARD6B. Isoform 2, but not at least isoform 3 interacts with PRKCZ. Interacts with PRCKI By similarity. Part of a complex with PARD6A or PARD6B, PRKCI or PRKCZ and CDC42 or RAC1. Interacts with F11R/JAM1 By similarity. Component of a complex whose core is composed of ARHGAP17, AMOT, MPP5/PALS1, INADL/PATJ and PARD3/PAR3. Interacts with LIMK2. Ref.1 Ref.4 Ref.10 Ref.11 Ref.16 |
| Subcellular location | Endomembrane system. Cell junction. Cell junction › tight junction. Cell membrane. Cytoplasm › cell cortex By similarity. Cytoplasm › cytoskeleton. Note: Localized along the cell-cell contact region. Colocalizes with PARD6A and PRKCI at epithelial tight junctions. Colocalizes with the cortical actin that overlays the meiotic spindle during metaphase I and metaphase II By similarity. |
| Tissue specificity | Widely expressed. Ref.4 |
| Domain | Contains a conserved N-terminal oligomerization domain (NTD) that is involved in oligomerization and is essential for proper subapical membrane localization By similarity. |
| Post-translational modification | Phosphorylated by PRKCZ. EGF-induced Tyr-1127 phosphorylation mediates dissociation from LIMK2. Ref.16 Ref.12 Ref.13 Ref.15 Ref.17 Ref.18 Ref.19 Ref.20 Ref.21 Ref.22 Ref.23 Ref.24 |
| Miscellaneous | Antibodies against PARD3 are present in sera from patients with cutaneous T-cell lymphomas. |
| Sequence similarities | Belongs to the PAR3 family. Contains 3 PDZ (DHR) domains. |
| Sequence caution | The sequence AAG33676.1 differs from that shown. Reason: Miscellaneous discrepancy. Contaminating sequence. Potential poly-A sequence. |
Ontologies
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| PARD6A | Q9NPB6 | 2 | EBI-81968,EBI-81876 | |
| PARD6B | Q9BYG5 | 1 | EBI-81968,EBI-295391 | |
| Pard6b | Q9JK83 | 2 | EBI-81968,EBI-81861 | From a different organism. |
| PARD6G | Q9BYG4 | 1 | EBI-81968,EBI-295417 | |
| PNMA1 | Q8ND90 | 1 | EBI-81968,EBI-302345 | |
| PRKCI | P41743 | 1 | EBI-81968,EBI-286199 | |
| STK11 | Q15831 | 1 | EBI-81968,EBI-306838 | |
| YWHAB | P31946 | 1 | EBI-81968,EBI-359815 | |
| YWHAG | P61981 | 1 | EBI-81968,EBI-359832 | |
| YWHAH | Q04917 | 1 | EBI-81968,EBI-306940 | |
| YWHAZ | P63104 | 1 | EBI-81968,EBI-347088 |
Alternative products
| This entry describes 10 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: Q8TEW0-1) Also known as: A; This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: Q8TEW0-2) Also known as: B; La; The sequence of this isoform differs from the canonical sequence as follows: 740-742: Missing. | ||||||
| Isoform 3 (identifier: Q8TEW0-3) Also known as: C; The sequence of this isoform differs from the canonical sequence as follows: 195-238: Missing. 557-569: Missing. 740-742: Missing. 827-856: Missing. | ||||||
| Isoform 4 (identifier: Q8TEW0-4) Also known as: D; The sequence of this isoform differs from the canonical sequence as follows: 1025-1061: Missing. | ||||||
| Isoform 5 (identifier: Q8TEW0-5) Also known as: E; The sequence of this isoform differs from the canonical sequence as follows: 195-238: Missing. 557-569: Missing. 740-742: Missing. 857-857: I → S 858-872: Missing. 1025-1061: Missing. | ||||||
| Isoform 6 (identifier: Q8TEW0-6) Also known as: F; The sequence of this isoform differs from the canonical sequence as follows: 557-569: Missing. 740-742: Missing. 827-856: Missing. | ||||||
| Isoform 7 (identifier: Q8TEW0-7) Also known as: Lb; The sequence of this isoform differs from the canonical sequence as follows: 557-569: Missing. 740-742: Missing. 827-856: Missing. 1025-1061: Missing. | ||||||
| Isoform 8 (identifier: Q8TEW0-8) Also known as: Sa; The sequence of this isoform differs from the canonical sequence as follows: 740-742: Missing. 1025-1034: RFGKHRKDDK → SLAKLKPEKR 1035-1356: Missing. | ||||||
| Isoform 9 (identifier: Q8TEW0-9) Also known as: Sb; The sequence of this isoform differs from the canonical sequence as follows: 557-569: Missing. 740-742: Missing. 827-856: Missing. 1025-1034: RFGKHRKDDK → SLAKLKPEKR 1035-1356: Missing. | ||||||
| Isoform 10 (identifier: Q8TEW0-10) The sequence of this isoform differs from the canonical sequence as follows: 740-742: Missing. 827-856: Missing. 857-858: IA → T 1025-1034: RFGKHRKDDK → SLAKLKPEKR 1035-1356: Missing. | ||||||
| Note: No experimental confirmation available. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 1356 | 1356 | Partitioning defective 3 homolog | PRO_0000185069 | |||||
Regions | |||||||||
| Domain | 271 – 359 | 89 | PDZ 1 | ||||||
| Domain | 461 – 546 | 86 | PDZ 2 | ||||||
| Domain | 590 – 677 | 88 | PDZ 3 | ||||||
| Region | 712 – 936 | 225 | Interacts with PRKCZ By similarity | ||||||
| Coiled coil | 1049 – 1077 | 29 | Potential | ||||||
| Coiled coil | 1151 – 1174 | 24 | Potential | ||||||
| Coiled coil | 1201 – 1224 | 24 | Potential | ||||||
| Coiled coil | 1280 – 1301 | 22 | Potential | ||||||
| Compositional bias | 984 – 1042 | 59 | Lys-rich | ||||||
Amino acid modifications | |||||||||
| Modified residue | 143 | 1 | Phosphoserine Ref.20 | ||||||
| Modified residue | 144 | 1 | Phosphoserine Ref.15 Ref.20 | ||||||
| Modified residue | 174 | 1 | Phosphoserine Ref.22 | ||||||
| Modified residue | 383 | 1 | Phosphoserine Ref.12 Ref.18 Ref.20 Ref.21 Ref.24 | ||||||
| Modified residue | 388 | 1 | Phosphotyrosine Ref.23 Ref.24 | ||||||
| Modified residue | 489 | 1 | Phosphotyrosine Ref.17 Ref.23 | ||||||
| Modified residue | 692 | 1 | Phosphoserine Ref.21 | ||||||
| Modified residue | 695 | 1 | Phosphoserine Ref.20 Ref.21 | ||||||
| Modified residue | 715 | 1 | Phosphoserine Ref.20 | ||||||
| Modified residue | 717 | 1 | Phosphoserine Ref.20 | ||||||
| Modified residue | 719 | 1 | Phosphotyrosine Ref.23 | ||||||
| Modified residue | 728 | 1 | Phosphoserine Ref.20 Ref.21 Ref.24 | ||||||
| Modified residue | 809 | 1 | Phosphoserine Ref.21 | ||||||
| Modified residue | 827 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 852 | 1 | Phosphoserine Ref.19 Ref.21 Ref.24 | ||||||
| Modified residue | 873 | 1 | Phosphoserine Ref.21 | ||||||
| Modified residue | 1005 | 1 | N6-acetyllysine Ref.25 | ||||||
| Modified residue | 1080 | 1 | Phosphotyrosine Ref.23 | ||||||
| Modified residue | 1127 | 1 | Phosphotyrosine Ref.16 Ref.13 Ref.23 | ||||||
Natural variations | |||||||||
| Alternative sequence | 195 – 238 | 44 | Missing in isoform 3 and isoform 5. | VSP_007462 | |||||
| Alternative sequence | 557 – 569 | 13 | Missing in isoform 3, isoform 5, isoform 6, isoform 7 and isoform 9. | VSP_007463 | |||||
| Alternative sequence | 740 – 742 | 3 | Missing in isoform 2, isoform 3, isoform 5, isoform 6, isoform 7, isoform 8, isoform 9 and isoform 10. | VSP_007464 | |||||
| Alternative sequence | 827 – 856 | 30 | Missing in isoform 3, isoform 6, isoform 7, isoform 9 and isoform 10. | VSP_007465 | |||||
| Alternative sequence | 857 – 858 | 2 | IA → T in isoform 10. | VSP_007467 | |||||
| Alternative sequence | 857 | 1 | I → S in isoform 5. | VSP_007466 | |||||
| Alternative sequence | 858 – 872 | 15 | Missing in isoform 5. | VSP_007468 | |||||
| Alternative sequence | 1025 – 1061 | 37 | Missing in isoform 4, isoform 5 and isoform 7. | VSP_007469 | |||||
| Alternative sequence | 1025 – 1034 | 10 | RFGKHRKDDK → SLAKLKPEKR in isoform 8, isoform 9 and isoform 10. | VSP_007470 | |||||
| Alternative sequence | 1035 – 1356 | 322 | Missing in isoform 8, isoform 9 and isoform 10. | VSP_007471 | |||||
| Natural variant | 107 | 1 | E → D: dbSNP rs1436731. | VAR_015663 | |||||
| Natural variant | 575 | 1 | D → N: dbSNP rs3758459. | VAR_050453 | |||||
Experimental info | |||||||||
| Mutagenesis | 1127 | 1 | Y → F: Delayed epithelial tight junction assembly. Ref.16 | ||||||
| Sequence conflict | 190 | 1 | T → A in BAB55330. Ref.7 | ||||||
| Sequence conflict | 233 | 1 | L → Q in BAB55330. Ref.7 | ||||||
| Sequence conflict | 594 | 1 | N → S in BAB55330. Ref.7 | ||||||
| Sequence conflict | 996 – 1000 | 5 | GKEKK → VELHE in BAA91366. Ref.7 | ||||||
Sequences
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "The cell-polarity protein Par6 links Par3 and atypical protein kinase C to Cdc42." Joberty G., Petersen C., Gao L., Macara I.G. Nat. Cell Biol. 2:531-539(2000) [PubMed: 10934474] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), INTERACTION WITH PARD6B. Tissue: Kidney. |
| [2] | "Down-regulated expression of atypical PKC-binding domain deleted asip isoforms in human hepatocellular carcinomas." Fang C.M., Xu Y.H. Cell Res. 11:223-229(2001) [PubMed: 11642408] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2; 3; 7; 8 AND 9). |
| [3] | "PAR3beta, a novel homologue of the cell polarity protein PAR3, localizes to tight junctions." Kohjima M., Noda Y., Takeya R., Saito N., Takeuchi K., Sumimoto H. Biochem. Biophys. Res. Commun. 299:641-646(2002) [PubMed: 12459187] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5). |
| [4] | "Multiple splice variants of Par3 and of a novel related gene, Par3L, produce proteins with different binding properties." Gao L., Macara I.G., Joberty G. Gene 294:99-107(2002) [PubMed: 12234671] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2; 3; 4; 5 AND 6), INTERACTION WITH PARD6B AND PRKCZ, TISSUE SPECIFICITY. |
| [5] | "The DNA sequence and comparative analysis of human chromosome 10." Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L., Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K., Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L., Taylor A., Battles J. Rogers J.Nature 429:375-381(2004) [PubMed: 15164054] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [6] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [7] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed: 14702039] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 126-1356 (ISOFORM 10). Tissue: Hepatoma and Ovarian carcinoma. |
| [8] | "Serological detection of cutaneous T-cell lymphoma-associated antigens." Eichmueller S., Usener D., Dummer R., Stein A., Thiel D., Schadendorf D. Proc. Natl. Acad. Sci. U.S.A. 98:629-634(2001) [PubMed: 11149944] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 313-992. Tissue: Testis. |
| [9] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 860-1356. Tissue: Lung. |
| [10] | "The mammalian homologue of the Caenorhabditis elegans polarity protein PAR-6 is a binding partner for the Rho GTPases Cdc42 and Rac1." Johansson A.-S., Driessens M., Aspenstroem P. J. Cell Sci. 113:3267-3275(2000) [PubMed: 10954424] [Abstract] Cited for: INTERACTION WITH PARD6A. |
| [11] | "Atypical protein kinase C is involved in the evolutionarily conserved par protein complex and plays a critical role in establishing epithelia-specific junctional structures." Suzuki A., Yamanaka T., Hirose T., Manabe N., Mizuno K., Shimizu M., Akimoto K., Izumi Y., Ohnishi T., Ohno S. J. Cell Biol. 152:1183-1196(2001) [PubMed: 11257119] [Abstract] Cited for: SUBUNIT OF A COMPLEX CONTAINING PARD6B AND PRKCI. Tissue: Kidney. |
| [12] | "Large-scale characterization of HeLa cell nuclear phosphoproteins." Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J., Li J., Cohn M.A., Cantley L.C., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004) [PubMed: 15302935] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-383, MASS SPECTROMETRY. Tissue: Epithelium. |
| [13] | "Time-resolved mass spectrometry of tyrosine phosphorylation sites in the epidermal growth factor receptor signaling network reveals dynamic modules." Zhang Y., Wolf-Yadlin A., Ross P.L., Pappin D.J., Rush J., Lauffenburger D.A., White F.M. Mol. Cell. Proteomics 4:1240-1250(2005) [PubMed: 15951569] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-1127, MASS SPECTROMETRY. Tissue: Epithelium. |
| [14] | "A Rich1/Amot complex regulates the Cdc42 GTPase and apical-polarity proteins in epithelial cells." Wells C.D., Fawcett J.P., Traweger A., Yamanaka Y., Goudreault M., Elder K., Kulkarni S., Gish G., Virag C., Lim C., Colwill K., Starostine A., Metalnikov P., Pawson T. Cell 125:535-548(2006) [PubMed: 16678097] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY, IDENTIFICATION IN A COMPLEX WITH ARHGAP17; AMOT; MPP5 AND INADL. |
| [15] | "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks." Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M. Cell 127:635-648(2006) [PubMed: 17081983] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-144, MASS SPECTROMETRY. Tissue: Epithelium. |
| [16] | "Tyrosine phosphorylated Par3 regulates epithelial tight junction assembly promoted by EGFR signaling." Wang Y., Du D., Fang L., Yang G., Zhang C., Zeng R., Ullrich A., Lottspeich F., Chen Z. EMBO J. 25:5058-5070(2006) [PubMed: 17053785] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-1127, MASS SPECTROMETRY, INTERACTION WITH LIMK2, MUTAGENESIS OF TYR-1127. |
| [17] | "Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer." Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J., Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L., Mitchell J., Wetzel R., Macneill J., Ren J.M. Comb M.J.Cell 131:1190-1203(2007) [PubMed: 18083107] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-489, MASS SPECTROMETRY. |
| [18] | "Improved titanium dioxide enrichment of phosphopeptides from HeLa cells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra." Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D. J. Proteome Res. 6:4150-4162(2007) [PubMed: 17924679] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-383, MASS SPECTROMETRY. Tissue: Epithelium. |
| [19] | "Phosphoproteome of resting human platelets." Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J., Schuetz C., Walter U., Gambaryan S., Sickmann A. J. Proteome Res. 7:526-534(2008) [PubMed: 18088087] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-852, MASS SPECTROMETRY. Tissue: Platelet. |
| [20] | "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis." Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III J. Proteome Res. 7:1346-1351(2008) [PubMed: 18220336] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-143; SER-144; SER-383; SER-695; SER-715; SER-717 AND SER-728, MASS SPECTROMETRY. |
| [21] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed: 18669648] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-383; SER-692; SER-695; SER-728; SER-809; SER-852 AND SER-873, MASS SPECTROMETRY. |
| [22] | "Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach." Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S. Anal. Chem. 81:4493-4501(2009) [PubMed: 19413330] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-174, MASS SPECTROMETRY. |
| [23] | "An extensive survey of tyrosine phosphorylation revealing new sites in human mammary epithelial cells." Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A., Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D., Wiley H.S., Qian W.-J. J. Proteome Res. 8:3852-3861(2009) [PubMed: 19534553] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-388; TYR-489; TYR-719; TYR-1080 AND TYR-1127, MASS SPECTROMETRY. Tissue: Mammary epithelium. |
| [24] | "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions." Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K. Sci. Signal. 2:RA46-RA46(2009) [PubMed: 19690332] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-383; TYR-388; SER-728 AND SER-852, MASS SPECTROMETRY. Tissue: T-cell. |
| [25] | "Lysine acetylation targets protein complexes and co-regulates major cellular functions." Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T., Olsen J.V., Mann M. Science 325:834-840(2009) [PubMed: 19608861] [Abstract] Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-1005, MASS SPECTROMETRY. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | AF252293 mRNA. Translation: AAF71530.1. AF196185 mRNA. Translation: AAK27891.1. AF196186 mRNA. Translation: AAK27892.1. AF332592 mRNA. Translation: AAK69192.1. AF332593 mRNA. Translation: AAK69193.1. AB073671 mRNA. Translation: BAC54037.1. AF467002 mRNA. Translation: AAL76042.1. AF467003 mRNA. Translation: AAL76043.1. AF467004 mRNA. Translation: AAL76044.1. AF467005 mRNA. Translation: AAL76045.1. AF467006 mRNA. Translation: AAL76046.1. AL360233 AL450337 Genomic DNA. Translation: CAH71161.1. AL360233 AL450337 Genomic DNA. Translation: CAH71162.1. AL360233 AL450337 Genomic DNA. Translation: CAH71163.1. AL360233 AL450337 Genomic DNA. Translation: CAH71166.1. AL360233 AL450337 Genomic DNA. Translation: CAH71167.1. AL160409 AL450337 Genomic DNA. Translation: CAH73524.1. AL160409 AL450337 Genomic DNA. Translation: CAH73525.1. AL160409 AL450337 Genomic DNA. Translation: CAH73526.1. AL160409 AL450337 Genomic DNA. Translation: CAH73529.1. AL450337 AL392123 Genomic DNA. Translation: CAI15036.1. AL450337 AL392123 Genomic DNA. Translation: CAI15037.1. AL450337 AL392123 Genomic DNA. Translation: CAI15038.1. AL450337 AL392123 Genomic DNA. Translation: CAI15040.1. AL450337 AL392123 Genomic DNA. Translation: CAI15041.1. AL138768 AL450337 Genomic DNA. Translation: CAI16985.1. AL138768 AL450337 Genomic DNA. Translation: CAI16986.1. AL138768 AL450337 Genomic DNA. Translation: CAI16987.1. AL138768 AL450337 Genomic DNA. Translation: CAI16989.1. AL138768 AL450337 Genomic DNA. Translation: CAI16991.1. AL390766 AL450337 Genomic DNA. Translation: CAI17304.1. AL390766 AL450337 Genomic DNA. Translation: CAI17305.1. AL390766 AL450337 Genomic DNA. Translation: CAI17306.1. AL390766 AL450337 Genomic DNA. Translation: CAI17309.1. AL390766 AL450337 Genomic DNA. Translation: CAI17310.1. AL392123 AL450337 Genomic DNA. Translation: CAI17327.1. AL392123 AL450337 Genomic DNA. Translation: CAI17328.1. AL392123 AL450337 Genomic DNA. Translation: CAI17329.1. AL392123 AL450337 Genomic DNA. Translation: CAI17332.1. AL392123 AL450337 Genomic DNA. Translation: CAI17333.1. AK000761 mRNA. Translation: BAA91366.1. Different initiation. AK027735 mRNA. Translation: BAB55330.1. Different initiation. AF177228 mRNA. Translation: AAG33676.1. Sequence problems. CH471072 Genomic DNA. Translation: EAW85932.1. BC011711 mRNA. Translation: AAH11711.2. | ||||||||||||
| IPI | IPI00045423. IPI00154915. IPI00163607. IPI00163608. IPI00165621. IPI00179063. IPI00294934. IPI00301595. IPI00301597. IPI00301605. | ||||||||||||
| RefSeq | NP_062565.2. | ||||||||||||
| UniGene | Hs.131489 | ||||||||||||
3D structure databases | |||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||
| SMR | Q8TEW0. Positions 2-83, 269-363, 279-549, 458-682, 582-685. | ||||||||||||
| ModBase | Search... | ||||||||||||
Protein-protein interaction databases | |||||||||||||
| IntAct | Q8TEW0. 18 interactions. | ||||||||||||
| STRING | Q8TEW0. | ||||||||||||
PTM databases | |||||||||||||
| PhosphoSite | Q8TEW0. | ||||||||||||
Proteomic databases | |||||||||||||
| PRIDE | Q8TEW0. | ||||||||||||
Genome annotation databases | |||||||||||||
| Ensembl | ENST00000374789; ENSP00000363921; ENSG00000148498; Homo sapiens. [Genome view] | ||||||||||||
| GeneID | 56288. | ||||||||||||
| KEGG | hsa:56288. | ||||||||||||
| UCSC | uc001ixg.1. human. uc001ixh.1. human. uc001ixi.1. human. uc001ixk.1. human. uc001ixl.1. human. uc001ixm.1. human. uc001ixn.1. human. uc001ixp.1. human. uc001ixq.1. human. uc001ixr.1. human. | ||||||||||||
Organism-specific databases | |||||||||||||
| CTD | 56288. | ||||||||||||
| GeneCards | GC10M034438. | ||||||||||||
| H-InvDB | HIX0008758. HIX0035395. | ||||||||||||
| HGNC | HGNC:16051. PARD3. | ||||||||||||
| MIM | 606745. gene. | ||||||||||||
| PharmGKB | PA32936. | ||||||||||||
| GenAtlas | Search... | ||||||||||||
Phylogenomic databases | |||||||||||||
| HOVERGEN | Q8TEW0. | ||||||||||||
| InParanoid | Q8TEW0. | ||||||||||||
| OMA | RTKQFSD. | ||||||||||||
| PhylomeDB | Q8TEW0. | ||||||||||||
Enzyme and pathway databases | |||||||||||||
| Reactome | REACT_20676. Cell junction organization. | ||||||||||||
Gene expression databases | |||||||||||||
| ArrayExpress | Q8TEW0. | ||||||||||||
| Bgee | Q8TEW0. | ||||||||||||
| Genevestigator | Q8TEW0. | ||||||||||||
| GermOnline | ENSG00000148498. Homo sapiens. | ||||||||||||
Family and domain databases | |||||||||||||
| InterPro | IPR001478. PDZ/DHR/GLGF. [Graphical view] | ||||||||||||
| Pfam | PF00595. PDZ. 3 hits. [Graphical view] | ||||||||||||
| SMART | SM00228. PDZ. 3 hits. [Graphical view] | ||||||||||||
| PROSITE | PS50106. PDZ. 3 hits. [Graphical view] | ||||||||||||
| ProtoNet | Search... | ||||||||||||
Other Resources | |||||||||||||
| NextBio | 61959. | ||||||||||||
| SOURCE | Search... | ||||||||||||
Entry information
| Entry name | PARD3_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q8TEW0 Secondary accession number(s): Q5T2U1 Q9NYE6 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation project | HPI (Human Proteome Initiative) | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 10 Human chromosome 10: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with


